Marshall Wace North America’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $550K | Sell |
31,361
-438,898
| -93% | -$7.7M | ﹤0.01% | 1052 |
|
|
2021
Q2 | $4.56M | Sell |
470,259
-399,282
| -46% | -$3.87M | 0.02% | 568 |
|
|
2021
Q1 | $9.34M | Sell |
869,541
-794,630
| -48% | -$8.53M | 0.04% | 409 |
|
|
2020
Q4 | $24.5M | Sell |
1,664,171
-545,172
| -25% | -$8.02M | 0.11% | 209 |
|
|
2020
Q3 | $31.4M | Sell |
2,209,343
-324,446
| -13% | -$4.61M | 0.2% | 130 |
|
|
2020
Q2 | $20.5M | Sell |
2,533,789
-54,172
| -2% | -$438K | 0.14% | 171 |
|
|
2020
Q1 | $10.5M | Buy |
+2,587,961
| New | +$10.5M | 0.08% | 217 |
|